Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Outcome of Application of Cryopreserved Amniotic Membrane Grafts in the Treatment of Chronic Nonhealing Wounds of Different Origins in Polymorbid Patients: A Prospective Multicenter Study

A. Svobodova, V. Horvath, L. Balogh, M. Zemlickova, R. Fiala, J. Burkert, M. Brabec, P. Stadler, J. Lindner, J. Bednar, K. Jirsova

. 2023 ; 10 (8) : . [pub] 20230729

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23015597

Grantová podpora
NV18-08-00106 Ministry of Health of the Czech Republic
LM2023033 Ministry of Education, Youth and Sports, Czech Republic
Medical Diagnostics and Basic Medical Sciences Charles University, Prague, Cooperatio
RVO 67985807 Institute of Computer Science, Czech Republic

To compare the therapeutic efficacy of cryopreserved amniotic membrane (AM) grafts and standard of care (SOC) in treating nonhealing wounds (NHW) through a prospective multicenter clinical trial, 42 patients (76% polymorbid) with 54 nonhealing wounds of various etiologies (mainly venous) and an average baseline size of 20 cm2 were included. All patients were treated for at least 6 weeks in the center before they were involved in the study. In the SOC group, 29 patients (36 wounds) were treated. If the wound healed less than 20% of the baseline size after 6 weeks, the patient was transferred to the AM group (35 patients, 43 wounds). Weekly visits included an assessment of the patient's condition, photo documentation, wound debridement, and dressing. Quality of life and the pain degree were subjectively reported by patients. After SOC, 7 wounds were healed completely, 1 defect partially, and 28 defects remained unhealed. AM application led to the complete closure of 24 wounds, partial healing occurred in 10, and 9 remained unhealed. The degree of pain and the quality of life improved significantly in all patients after AM application. This study demonstrates the effectiveness of cryopreserved AM grafts in the healing of NHW of polymorbid patients and associated pain reduction.

000      
00000naa a2200000 a 4500
001      
bmc23015597
003      
CZ-PrNML
005      
20240223082542.0
007      
ta
008      
231010s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/bioengineering10080900 $2 doi
035    __
$a (PubMed)37627785
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Svobodova, Alzbeta $u 2nd Department of Surgery-Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
245    10
$a Outcome of Application of Cryopreserved Amniotic Membrane Grafts in the Treatment of Chronic Nonhealing Wounds of Different Origins in Polymorbid Patients: A Prospective Multicenter Study / $c A. Svobodova, V. Horvath, L. Balogh, M. Zemlickova, R. Fiala, J. Burkert, M. Brabec, P. Stadler, J. Lindner, J. Bednar, K. Jirsova
520    9_
$a To compare the therapeutic efficacy of cryopreserved amniotic membrane (AM) grafts and standard of care (SOC) in treating nonhealing wounds (NHW) through a prospective multicenter clinical trial, 42 patients (76% polymorbid) with 54 nonhealing wounds of various etiologies (mainly venous) and an average baseline size of 20 cm2 were included. All patients were treated for at least 6 weeks in the center before they were involved in the study. In the SOC group, 29 patients (36 wounds) were treated. If the wound healed less than 20% of the baseline size after 6 weeks, the patient was transferred to the AM group (35 patients, 43 wounds). Weekly visits included an assessment of the patient's condition, photo documentation, wound debridement, and dressing. Quality of life and the pain degree were subjectively reported by patients. After SOC, 7 wounds were healed completely, 1 defect partially, and 28 defects remained unhealed. AM application led to the complete closure of 24 wounds, partial healing occurred in 10, and 9 remained unhealed. The degree of pain and the quality of life improved significantly in all patients after AM application. This study demonstrates the effectiveness of cryopreserved AM grafts in the healing of NHW of polymorbid patients and associated pain reduction.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Horvath, Vojtech $u Department of Vascular Surgery, Na Homolce Hospital, 150 30 Prague, Czech Republic
700    1_
$a Balogh, Lukáš $u Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic $7 xx0314475
700    1_
$a Zemlickova, Martina $u Clinic of Dermatovenerology, General Teaching Hospital and First Faculty of Medicine, Charles University, 121 08 Prague, Czech Republic
700    1_
$a Fiala, Radovan $u Department of Cardiovascular Surgery, Motol University Hospital, 150 06 Prague, Czech Republic
700    1_
$a Burkert, Jan $u Department of Cardiovascular Surgery, Motol University Hospital, 150 06 Prague, Czech Republic $u Department of Transplantation and Tissue Bank, Motol University Hospital, 150 06 Prague, Czech Republic $1 https://orcid.org/0000000195660527
700    1_
$a Brabec, Marek $u Department of Statistical Modeling, Institute of Computer Science, The Czech Academy of Sciences, 182 07 Prague, Czech Republic
700    1_
$a Stadler, Petr $u Department of Vascular Surgery, Na Homolce Hospital, 150 30 Prague, Czech Republic
700    1_
$a Lindner, Jaroslav $u 2nd Department of Surgery-Department of Cardiovascular Surgery, First Faculty of Medicine, Charles University and General University Hospital in Prague, 128 08 Prague, Czech Republic
700    1_
$a Bednar, Jan $u Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic
700    1_
$a Jirsova, Katerina $u Laboratory of the Biology and Pathology of the Eye, Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic $u Department of Transplantation and Tissue Bank, Motol University Hospital, 150 06 Prague, Czech Republic $1 https://orcid.org/0000000246256701 $7 xx0101780
773    0_
$w MED00193488 $t Bioengineering $x 2306-5354 $g Roč. 10, č. 8 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37627785 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231010 $b ABA008
991    __
$a 20240223082536 $b ABA008
999    __
$a ok $b bmc $g 1997201 $s 1201959
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 10 $c 8 $e 20230729 $i 2306-5354 $m Bioengineering $n Bioengineering (Basel) $x MED00193488
GRA    __
$a NV18-08-00106 $p Ministry of Health of the Czech Republic
GRA    __
$a LM2023033 $p Ministry of Education, Youth and Sports, Czech Republic
GRA    __
$a Medical Diagnostics and Basic Medical Sciences $p Charles University, Prague, Cooperatio
GRA    __
$a RVO 67985807 $p Institute of Computer Science, Czech Republic
LZP    __
$a Pubmed-20231010

Najít záznam

Citační ukazatele

Možnosti archivace